The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol.

Peter NovodvorskyLenka ThiemeIvana LaňkováMiloš MrázZoltán J TaybaniBalázs BótyikPéter StellaMiroslav VytasilFelipe LauandMireille BonnemaireMartin Haluzík

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)

ClinicalTrials.gov, identifier NCT04945070.

Keyphrases

type diabetes
study protocol
randomized controlled trial
glycemic control
stem cells
clinical trial
bone marrow
cell therapy
insulin resistance
weight loss